Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new collaborative project led by the Swietach group funded by the Propionic Acidemia Foundation will investigate the disease mechanisms and risk factors for cardiac disease caused by a severe inherited disorder.

Pawel SwietachPropionic acidemia (PA) is an inherited metabolic disorder affecting newborns and children in which the body cannot break down parts of protein and some types of fat. This inability causes a build-up of harmful substances such as propionic acid in the blood which can cause seizures, delays to normal development like walking and talking, and other health problems. 

Cardiac problems are common in PA, and dilated cardiomyopathy and long-QT syndrome are often the cause of childhood death. In order to treat and prevent these cardiac problems, it is necessary to understand the underlying mechanisms. Professor Pawel Swietach has been awarded a research grant from the Propionic Acidemia Foundation to learn more about these mechanisms and, once processes are described, identify targets for drugs or other interventions. According to Professor Swietach: "We believe that this ambition is achievable thanks to the wealth of knowledge about the heart and the vast repertoire of drugs approved for therapy in various other cardiac conditions. Many of these drugs could be “repurposed” for PA-associated disorders, giving hope to many families for a timely treatment."

Professor Swietach will be collaborating with Tom Milne, Associate Professor in Epigenetics at Oxford, Holger Kramer, an expert on proteomics, and Steve Krywawych, principal biochemist at Great Ormond Street Hospital in London. 

More information about the PAF award can be found in the Propionic Acidemia Foundation newsletter Spring 2021 (page 2).

Similar stories

Kaitlyn Dennis to receive the William C Stanley Early Investigator Award

Congratulations are in order for DPhil student Kaitlyn Dennis, who has been awarded the William C Stanley Early Investigator Award. The award highlights the scientific accomplishments of promising young researchers and is a major focus of the Annual Meeting of the Society for Heart and Vascular Metabolism.

Zoltán Molnár delivers Keynote Lecture at first-of-its-kind Anatomical conference

Professor Zoltán Molnár delivers the first Keynote Lecture at the 116th Annual Meeting of the Anatomische Gesellschaft, which this year is held as a Joint Meeting with the Anatomical Society for the first time.

Becky Carlyle funded by leading dementia research charity to reveal new targets for Alzheimer's

Senior Postdoctoral Research Scientist Dr Becky Carlyle has been awarded a £420K funding boost from Alzheimer’s Research UK.

Gero Miesenböck awarded Horwitz Prize for foundational work on Optogenetics

Congratulations are in order for Professor Gero Miesenböck, who is to be awarded the 2022 Louisa Gross Horwitz Prize, together with Professors Karl Deisseroth and Peter Hegemann, for research that laid the foundation for the field of optogenetics.

DPAG has two new Professors

Congratulations are in order to Ana Domingos and Nicola Smart who have been awarded the title of Professor in the recent Recognition of Distinction round.